Abstract
Claims have been made that hyperactive children respond better to stimulant treatment if they have clinical indicators of neurological dysfunction. However, studies report conflicting results. The present placebo-controlled study examined the relationship between neurological abnormalities and stimulant medication efficacy in 80 pervasively hyperactive children. Treatment outcome measures, which were adjusted for both age and initial severity of the disorder, included teacher and psychiatric ratings. No evidence was found to indicate that clinical neurological status, including encephalographic and neurological soft signs, was predictive of drug responsivity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the American Academy of Child Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.